With the help of $35 Million, Cardiac Dimensions has Developed a Device to Treat a Condition Linked to Heart Failure

With the help of $35 Million, Cardiac Dimensions has Developed a Device to Treat a Condition Linked to Heart Failure

Cardiac Dimensions, a medical device company in Kirkland, Washington, got $35 million to help test and sell its mitral valve regurgitation treatment system. Mitral valve regurgitation is the backflow of blood through the mitral valve during left ventricular contraction. This condition is associated with an enlarged heart and congestive heart failure. The Carillon Mitral Contour System is meant to tighten the leaking valve in a way that doesn’t hurt the patient too much.

advertisement
Battle Approved Motors. Invest Today!!
advertisement
Get a $250 Amazon Gift Card. Apply Today!

About Davie Bancroft

Davie Bancroft is an accomplished author with a strong focus on investment and the tech business landscape. With extensive knowledge and experience in these fields, he provides valuable insights into emerging trends and opportunities. Davie's writings explore the intersection of technology and finance, offering practical advice for investors and entrepreneurs. His expertise and analytical approach make him a trusted resource for those seeking to navigate the dynamic world of investments and tech startups.

See Articles by Davie Bancroft

Search